BeStock  
Markets › Compare › PGEN vs VIR

PGEN vs VIR

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
PGEN · Precigen$4.21 ▲ 1.20%
VIR · Vir Biotechnology$8.39 ▼ 5.41%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

73113153193233Nov 24, '25May 26, '26Nov 20, '26
  • PGEN +10.2%
  • VIR +37.1%

Head to head

MetricPGENVIR
Price$4.21$8.39
Change today▲ 1.20%▼ 5.41%
Market cap$1.51B$1.56B
Return, 3 months-41.3%-15.3%
Return, year to date+0.7%+39.1%
Return, 1 year+8.5%+47.7%
P/E (TTM)38.3–
P/B18.01.7
P/E percentile vs own 5y100th11th
Dividend yield––
Revenue growth (YoY, latest qtr)+2,437.6%-207.7%
Net profit growth (YoY)+124.4%+41.0%
Gross margin91.4%100.0%
Operating margin21.4%-69.9%
Net margin15.6%-61.1%
Return on equity38.8%-21.8%
Analyst target vs. price+232.5%+167.3%
Analyst buy share100%100%
RSI (14)3233
30-day volatility117.7%92.6%
Max drawdown, 1 year-51.4%-38.5%
Trend readStrong downtrendStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • VIR is the largest of the group by market value.
  • VIR has returned the most over the past year.
  • PGEN is growing revenue fastest.
  • PGEN keeps the most profit per dollar of sales.
  • VIR has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top